| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MPP1 TNIK DDR1 POLR1A TRIO KALRN LMTK2 ELP1 OAS3 SIK3 TRRAP LIMK2 SPHK1 PI4KB FGFR2 TAF1 IPMK REV1 | 1.24e-05 | 938 | 120 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 3.58e-05 | 2 | 120 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 3.58e-05 | 2 | 120 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 3.58e-05 | 2 | 120 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 3.58e-05 | 2 | 120 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | kinase activity | MPP1 TNIK DDR1 TRIO KALRN LMTK2 ELP1 SIK3 TRRAP LIMK2 SPHK1 PI4KB FGFR2 TAF1 IPMK | 5.43e-05 | 764 | 120 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK DDR1 TRIO KALRN LMTK2 ELP1 SIK3 LIMK2 SPHK1 PI4KB FGFR2 TAF1 IPMK | 3.41e-04 | 709 | 120 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | PMS1 POLR1A RPP40 MEIOB SLU7 TDP2 MSH6 SMARCA2 PARN DNASE1L1 PUS7 REV1 | 5.11e-04 | 645 | 120 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | L-leucine binding | 7.37e-04 | 7 | 120 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.04e-03 | 262 | 120 | 7 | GO:0140097 | |
| GeneOntologyBiologicalProcess | neuron development | TNIK DDR1 IFT140 ARHGAP32 FAT4 RPGRIP1L TRIO KALRN PRICKLE1 FAT3 L1CAM LMTK2 LAMB3 TSC1 CSMD3 TNFRSF21 TENM2 TDP2 PRDM1 NRXN1 SPHK1 SCN1B MTR ROBO1 FGFR2 PREX1 VPS13B | 6.28e-08 | 1463 | 120 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | TNIK DDR1 ARHGAP32 FAT4 TRIO KALRN PRICKLE1 FAT3 L1CAM LMTK2 LAMB3 TSC1 CSMD3 TNFRSF21 TENM2 NRXN1 SPHK1 SCN1B MTR ROBO1 FGFR2 PREX1 VPS13B | 1.21e-06 | 1285 | 120 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TNIK DDR1 IFT140 ARHGAP32 KALRN FAT3 L1CAM MARCHF7 TSC1 CSMD3 TENM2 KIF24 LIMK2 NRXN1 SPHK1 SCN1B ROBO1 PREX1 | 1.91e-06 | 846 | 120 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.20e-06 | 313 | 120 | 11 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TNIK DDR1 IFT140 ARHGAP32 KALRN FAT3 L1CAM MARCHF7 TSC1 CSMD3 TENM2 KIF24 LIMK2 NRXN1 SPHK1 SCN1B ROBO1 PREX1 | 2.53e-06 | 863 | 120 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | axon development | DDR1 ARHGAP32 TRIO KALRN PRICKLE1 L1CAM LMTK2 LAMB3 TNFRSF21 TENM2 NRXN1 SCN1B MTR ROBO1 FGFR2 | 4.88e-06 | 642 | 120 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.39e-05 | 187 | 120 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 3.29e-05 | 63 | 120 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | negative regulation of protein autoubiquitination | 3.36e-05 | 2 | 120 | 2 | GO:1905524 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.44e-05 | 285 | 120 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | synapse organization | IL10RA SDK2 CTTNBP2 KALRN PRICKLE1 L1CAM NBEA TSC1 C1QL2 NRXN1 ROBO1 FGFR2 CDH9 CDH10 | 4.53e-05 | 685 | 120 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.56e-05 | 286 | 120 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TNIK DDR1 ARHGAP32 KALRN FAT3 L1CAM TSC1 CSMD3 NRXN1 SPHK1 SCN1B ROBO1 PREX1 | 5.83e-05 | 612 | 120 | 13 | GO:0010975 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TNIK DDR1 ARHGAP32 TRIO KALRN PRICKLE1 FAT3 L1CAM LMTK2 LAMB3 TENM2 ADD1 NRXN1 SCN1B ROBO1 FGFR2 DNMBP CDH9 CDH10 | 5.88e-05 | 1194 | 120 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | sensory organ development | DDR1 IFT140 FAT4 SDK2 RPGRIP1L PRICKLE1 FAT3 ESRP1 PRDM1 LIMK2 PXDN PI4KB FGFR2 USH2A | 8.93e-05 | 730 | 120 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TNIK ARHGAP32 TRIO KALRN PRICKLE1 FAT3 L1CAM LMTK2 LAMB3 TENM2 NRXN1 SCN1B ROBO1 FGFR2 | 1.15e-04 | 748 | 120 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 TRIO KALRN PRICKLE1 L1CAM LMTK2 LAMB3 TENM2 NRXN1 SCN1B ROBO1 FGFR2 | 1.16e-04 | 566 | 120 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 1.35e-04 | 45 | 120 | 4 | GO:0060603 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma membrane bounded cell projection assembly | 1.35e-04 | 45 | 120 | 4 | GO:0120033 | |
| GeneOntologyBiologicalProcess | tube development | DDR1 IFT140 FAT4 RPGRIP1L PRICKLE1 ESRP1 TSC1 ADD1 PRDM1 PXDN NRXN1 SPHK1 UMOD ROBO1 TBXT TNFAIP2 FGFR2 CSMD1 IPMK TNS3 | 1.64e-04 | 1402 | 120 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.78e-04 | 421 | 120 | 10 | GO:0060562 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 1.89e-04 | 49 | 120 | 4 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 1.89e-04 | 49 | 120 | 4 | GO:0099633 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 2.25e-04 | 278 | 120 | 8 | GO:0031503 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TNIK DDR1 ARHGAP32 TRIO KALRN PRICKLE1 L1CAM LMTK2 LAMB3 TENM2 NRXN1 SCN1B ROBO1 FGFR2 | 2.37e-04 | 802 | 120 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 2.47e-04 | 150 | 120 | 6 | GO:0050773 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK DDR1 ARHGAP32 TRIO KALRN PRICKLE1 L1CAM LMTK2 LAMB3 TENM2 NRXN1 SCN1B ROBO1 FGFR2 | 2.94e-04 | 819 | 120 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 3.11e-04 | 101 | 120 | 5 | GO:0097120 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium assembly | 3.12e-04 | 23 | 120 | 3 | GO:1902018 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK DDR1 ARHGAP32 TRIO KALRN PRICKLE1 L1CAM LMTK2 LAMB3 TENM2 NRXN1 SCN1B ROBO1 FGFR2 | 3.20e-04 | 826 | 120 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 3.28e-04 | 294 | 120 | 8 | GO:0044706 | |
| GeneOntologyBiologicalProcess | glutamate biosynthetic process | 3.32e-04 | 5 | 120 | 2 | GO:0006537 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | DDR1 IFT140 FAT4 COL10A1 SDK2 RPGRIP1L PRICKLE1 FAT3 ESRP1 LAMB3 SIK3 PRDM1 ROBO1 TBXT FGFR2 DMP1 CSMD1 USH2A | 3.87e-04 | 1269 | 120 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 4.02e-04 | 25 | 120 | 3 | GO:0098696 | |
| GeneOntologyBiologicalProcess | renal system development | 4.32e-04 | 386 | 120 | 9 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of protein autoubiquitination | 4.96e-04 | 6 | 120 | 2 | GO:1902498 | |
| GeneOntologyBiologicalProcess | response to aluminum ion | 4.96e-04 | 6 | 120 | 2 | GO:0010044 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 SDK2 DSG3 PRICKLE1 FAT3 L1CAM MARCHF7 TNFRSF21 TENM2 NRXN1 SMARCA2 UMOD ROBO1 SIGLEC1 CDH9 CDH10 | 5.10e-04 | 1077 | 120 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction organization | IL10RA SDK2 CTTNBP2 KALRN PRICKLE1 L1CAM NBEA TSC1 ADD1 C1QL2 NRXN1 ROBO1 FGFR2 CDH9 CDH10 | 5.33e-04 | 974 | 120 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 5.61e-04 | 65 | 120 | 4 | GO:0060443 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 5.65e-04 | 115 | 120 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TNIK DDR1 ARHGAP32 KALRN L1CAM TENM2 NRXN1 SPHK1 SCN1B ROBO1 | 6.27e-04 | 494 | 120 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 7.59e-04 | 334 | 120 | 8 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 7.59e-04 | 334 | 120 | 8 | GO:0001894 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | DDR1 FAT4 PRICKLE1 ESRP1 TSC1 ADD1 PRDM1 PXDN NRXN1 SPHK1 ROBO1 TBXT TNFAIP2 FGFR2 CSMD1 IPMK | 8.15e-04 | 1125 | 120 | 16 | GO:0035239 |
| MousePheno | increased grooming behavior | 8.81e-07 | 74 | 99 | 7 | MP:0001441 | |
| MousePheno | abnormal social investigation | 2.83e-05 | 171 | 99 | 8 | MP:0001360 | |
| MousePheno | abnormal social/conspecific interaction behavior | SEMG1 ARHGAP32 CTTNBP2 DCAF8 KALRN PRICKLE1 L1CAM NBEA TSC1 CSMD3 NRXN1 PREX1 | 4.12e-05 | 421 | 99 | 12 | MP:0002557 |
| MousePheno | abnormal grooming behavior | 5.24e-05 | 137 | 99 | 7 | MP:0001440 | |
| MousePheno | absent limb buds | 9.36e-05 | 13 | 99 | 3 | MP:0004573 | |
| MousePheno | abnormal thoracic cage morphology | IFT140 FAT4 RPGRIP1L DSG3 PRICKLE1 SIK3 ANKRD18B TBXT FGFR2 DMP1 CSMD1 ST18 | 1.02e-04 | 463 | 99 | 12 | MP:0004624 |
| MousePheno | eye inflammation | 1.65e-04 | 73 | 99 | 5 | MP:0001851 | |
| MousePheno | abnormal kidney morphology | DDR1 IFT140 FAT4 RPGRIP1L PRICKLE1 ESRP1 ANKRD26 LMTK2 ELP1 TSC1 SIK3 MEP1A C1QL2 LIMK2 SPHK1 UMOD ROBO1 SIGLEC1 TNFAIP2 FGFR2 DMP1 DNMBP | 1.77e-04 | 1363 | 99 | 22 | MP:0002135 |
| MousePheno | abnormal synchondrosis | 1.80e-04 | 16 | 99 | 3 | MP:0004053 | |
| MousePheno | abnormal tongue morphology | 1.88e-04 | 118 | 99 | 6 | MP:0000762 | |
| MousePheno | abnormal renal tubule morphology | 2.06e-04 | 227 | 99 | 8 | MP:0002703 | |
| MousePheno | abnormal proximal convoluted tubule morphology | 2.12e-04 | 77 | 99 | 5 | MP:0004756 | |
| Domain | Ig_I-set | FCRL2 SDK2 TRIO KALRN L1CAM PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 4.46e-07 | 190 | 121 | 10 | IPR013098 |
| Domain | I-set | FCRL2 SDK2 TRIO KALRN L1CAM PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 4.46e-07 | 190 | 121 | 10 | PF07679 |
| Domain | IGc2 | FCRL2 SDK2 TRIO KALRN L1CAM PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 3.07e-06 | 235 | 121 | 10 | SM00408 |
| Domain | Ig_sub2 | FCRL2 SDK2 TRIO KALRN L1CAM PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 3.07e-06 | 235 | 121 | 10 | IPR003598 |
| Domain | - | IL10RA FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 SCN1B ROBO1 TGM7 SIGLEC1 FGFR2 USH2A | 2.53e-05 | 663 | 121 | 15 | 2.60.40.10 |
| Domain | ELFV_dehydrog_N | 4.16e-05 | 2 | 121 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 4.16e-05 | 2 | 121 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 4.16e-05 | 2 | 121 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 4.16e-05 | 2 | 121 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 4.16e-05 | 2 | 121 | 2 | PF00208 | |
| Domain | TMEM151 | 4.16e-05 | 2 | 121 | 2 | PF14857 | |
| Domain | NAD_bind_Glu_DH | 4.16e-05 | 2 | 121 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 4.16e-05 | 2 | 121 | 2 | PS00074 | |
| Domain | Tmem151 | 4.16e-05 | 2 | 121 | 2 | IPR026767 | |
| Domain | ELFV_dehydrog | 4.16e-05 | 2 | 121 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 4.16e-05 | 2 | 121 | 2 | IPR033524 | |
| Domain | EGF_1 | 4.28e-05 | 255 | 121 | 9 | PS00022 | |
| Domain | Ig-like_fold | IL10RA FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 SCN1B ROBO1 TGM7 SIGLEC1 FGFR2 USH2A | 5.20e-05 | 706 | 121 | 15 | IPR013783 |
| Domain | DH_1 | 5.47e-05 | 63 | 121 | 5 | PS00741 | |
| Domain | RhoGEF | 7.90e-05 | 68 | 121 | 5 | SM00325 | |
| Domain | IG_LIKE | FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 SCN1B ROBO1 SIGLEC1 FGFR2 | 8.33e-05 | 491 | 121 | 12 | PS50835 |
| Domain | RhoGEF | 9.08e-05 | 70 | 121 | 5 | PF00621 | |
| Domain | DH_2 | 9.08e-05 | 70 | 121 | 5 | PS50010 | |
| Domain | IG | FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 9.27e-05 | 421 | 121 | 11 | SM00409 |
| Domain | Ig_sub | FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 ROBO1 SIGLEC1 FGFR2 | 9.27e-05 | 421 | 121 | 11 | IPR003599 |
| Domain | - | 9.72e-05 | 71 | 121 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 9.72e-05 | 71 | 121 | 5 | IPR000219 | |
| Domain | LAM_G_DOMAIN | 1.04e-04 | 38 | 121 | 4 | PS50025 | |
| Domain | Ig-like_dom | FCRL2 SDK2 TRIO KALRN L1CAM BTN3A3 PXDN CEACAM21 SCN1B ROBO1 SIGLEC1 FGFR2 | 1.05e-04 | 503 | 121 | 12 | IPR007110 |
| Domain | Cadherin | 1.19e-04 | 118 | 121 | 6 | IPR002126 | |
| Domain | Laminin_G_2 | 1.28e-04 | 40 | 121 | 4 | PF02210 | |
| Domain | LamG | 1.86e-04 | 44 | 121 | 4 | SM00282 | |
| Domain | EGF-like_CS | 3.02e-04 | 261 | 121 | 8 | IPR013032 | |
| Domain | EGF_2 | 3.34e-04 | 265 | 121 | 8 | PS01186 | |
| Domain | - | 3.82e-04 | 95 | 121 | 5 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 4.84e-04 | 100 | 121 | 5 | PS00010 | |
| Domain | Laminin_G | 5.43e-04 | 58 | 121 | 4 | IPR001791 | |
| Domain | Cadherin_C | 5.50e-04 | 25 | 121 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.50e-04 | 25 | 121 | 3 | IPR000233 | |
| Domain | ConA-like_dom | 5.65e-04 | 219 | 121 | 7 | IPR013320 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.32e-04 | 106 | 121 | 5 | IPR000152 | |
| Domain | Cadherin_CS | 7.17e-04 | 109 | 121 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 8.44e-04 | 113 | 121 | 5 | PS00232 | |
| Domain | Cadherin | 8.44e-04 | 113 | 121 | 5 | PF00028 | |
| Domain | EGF | 8.56e-04 | 235 | 121 | 7 | SM00181 | |
| Domain | EGF_3 | 8.56e-04 | 235 | 121 | 7 | PS50026 | |
| Domain | Catenin_binding_dom | 8.57e-04 | 29 | 121 | 3 | IPR027397 | |
| Domain | - | 8.57e-04 | 29 | 121 | 3 | 4.10.900.10 | |
| Domain | CADHERIN_2 | 8.79e-04 | 114 | 121 | 5 | PS50268 | |
| Domain | - | 8.79e-04 | 114 | 121 | 5 | 2.60.40.60 | |
| Domain | CA | 9.14e-04 | 115 | 121 | 5 | SM00112 | |
| Domain | Cadherin-like | 9.50e-04 | 116 | 121 | 5 | IPR015919 | |
| Domain | EGF_CA | 1.19e-03 | 122 | 121 | 5 | SM00179 | |
| Domain | EGF-like_dom | 1.20e-03 | 249 | 121 | 7 | IPR000742 | |
| Domain | EGF-like_Ca-bd_dom | 1.28e-03 | 124 | 121 | 5 | IPR001881 | |
| Domain | Ig_V-set | 1.89e-03 | 199 | 121 | 6 | IPR013106 | |
| Domain | GDS_CDC24_CS | 2.04e-03 | 39 | 121 | 3 | IPR001331 | |
| Domain | EGF_CA | 2.36e-03 | 86 | 121 | 4 | PF07645 | |
| Domain | FN3_dom | 2.42e-03 | 209 | 121 | 6 | IPR003961 | |
| Domain | EGF_dom | 2.63e-03 | 12 | 121 | 2 | IPR024731 | |
| Domain | EGF_3 | 2.63e-03 | 12 | 121 | 2 | PF12947 | |
| Domain | Kinase-like_dom | 2.77e-03 | 542 | 121 | 10 | IPR011009 | |
| Domain | Ank_2 | 2.78e-03 | 215 | 121 | 6 | PF12796 | |
| Domain | SH3 | 2.85e-03 | 216 | 121 | 6 | SM00326 | |
| Domain | SH3 | 2.85e-03 | 216 | 121 | 6 | PS50002 | |
| Domain | SH3_domain | 3.12e-03 | 220 | 121 | 6 | IPR001452 | |
| Domain | EGF_Ca-bd_CS | 3.65e-03 | 97 | 121 | 4 | IPR018097 | |
| Domain | Ank | 3.71e-03 | 228 | 121 | 6 | PF00023 | |
| Domain | EGF_CA | 3.93e-03 | 99 | 121 | 4 | PS01187 | |
| Domain | CUB | 3.93e-03 | 49 | 121 | 3 | PF00431 | |
| Domain | fn3 | 4.09e-03 | 162 | 121 | 5 | PF00041 | |
| Domain | BAR | 4.14e-03 | 15 | 121 | 2 | SM00721 | |
| Domain | CNH | 4.14e-03 | 15 | 121 | 2 | PF00780 | |
| Domain | BAR | 4.14e-03 | 15 | 121 | 2 | PF03114 | |
| Domain | CNH | 4.14e-03 | 15 | 121 | 2 | PS50219 | |
| Domain | CNH_dom | 4.14e-03 | 15 | 121 | 2 | IPR001180 | |
| Domain | CUB | 4.16e-03 | 50 | 121 | 3 | SM00042 | |
| Domain | - | 4.65e-03 | 52 | 121 | 3 | 2.60.120.290 | |
| Domain | - | 4.71e-03 | 16 | 121 | 2 | 1.10.1070.11 | |
| Domain | Laminin_N | 4.71e-03 | 16 | 121 | 2 | IPR008211 | |
| Domain | BAR_dom | 4.71e-03 | 16 | 121 | 2 | IPR004148 | |
| Domain | PI3Kc | 4.71e-03 | 16 | 121 | 2 | SM00146 | |
| Domain | LamNT | 4.71e-03 | 16 | 121 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 4.71e-03 | 16 | 121 | 2 | PS51117 | |
| Domain | Laminin_N | 4.71e-03 | 16 | 121 | 2 | PF00055 | |
| Domain | CUB | 4.91e-03 | 53 | 121 | 3 | PS01180 | |
| Domain | - | 5.57e-03 | 248 | 121 | 6 | 1.25.40.20 | |
| Domain | ANK | 5.90e-03 | 251 | 121 | 6 | SM00248 | |
| Domain | PI3_PI4_kinase | 5.95e-03 | 18 | 121 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.95e-03 | 18 | 121 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.95e-03 | 18 | 121 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.95e-03 | 18 | 121 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.95e-03 | 18 | 121 | 2 | PS50290 | |
| Domain | CUB_dom | 6.02e-03 | 57 | 121 | 3 | IPR000859 | |
| Domain | ANK_REPEAT | 6.13e-03 | 253 | 121 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 6.25e-03 | 254 | 121 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 6.25e-03 | 254 | 121 | 6 | PS50297 | |
| Pubmed | Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring. | 2.50e-06 | 8 | 125 | 3 | 30177526 | |
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 2.50e-06 | 8 | 125 | 3 | 34135511 | |
| Pubmed | 7.32e-06 | 11 | 125 | 3 | 24349473 | ||
| Pubmed | MRG15 is a novel PALB2-interacting factor involved in homologous recombination. | 9.74e-06 | 12 | 125 | 3 | 19553677 | |
| Pubmed | TNIK ARHGAP32 CTTNBP2 TRIO KALRN NBEA TSC1 SIK3 TENM2 ADD1 NRXN1 PARN SSH2 CDH10 | 1.01e-05 | 963 | 125 | 14 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO KALRN CTC1 PHF12 L1CAM LMTK2 LAMB3 EML2 TRRAP TNFRSF21 SPHK1 TNFAIP2 FGFR2 DNMBP PREX1 | 1.07e-05 | 1105 | 125 | 15 | 35748872 |
| Pubmed | SEMG1 IFT140 DCAF8 PHF12 FAT3 OAS3 SIK3 TRRAP MSH6 LIMK2 SMARCA2 MTR SIGLEC1 TAF1 CSMD1 | 1.21e-05 | 1116 | 125 | 15 | 31753913 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34173171 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28621566 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32078638 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23595828 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21621574 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28911206 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22875990 | ||
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 1.28e-05 | 2 | 125 | 2 | 15578726 | |
| Pubmed | Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes. | 1.28e-05 | 2 | 125 | 2 | 15044002 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 1.28e-05 | 2 | 125 | 2 | 22138648 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34220417 | ||
| Pubmed | Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. | 1.28e-05 | 2 | 125 | 2 | 26241911 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21446915 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38060673 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24593767 | ||
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 1.28e-05 | 2 | 125 | 2 | 37154294 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22924626 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11032875 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 1.28e-05 | 2 | 125 | 2 | 26858404 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29943084 | ||
| Pubmed | Common genetic variants on 5p14.1 associate with autism spectrum disorders. | 1.28e-05 | 2 | 125 | 2 | 19404256 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 1.28e-05 | 2 | 125 | 2 | 15378063 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27422263 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15750346 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 1711373 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 1.28e-05 | 2 | 125 | 2 | 20529287 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22846907 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24077287 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25124006 | ||
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 1.28e-05 | 2 | 125 | 2 | 23673664 | |
| Pubmed | Lack of evidence for direct ligand-gated ion channel activity of GluD receptors. | 1.28e-05 | 2 | 125 | 2 | 39052831 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24442550 | ||
| Pubmed | The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity. | 1.28e-05 | 2 | 125 | 2 | 27137930 | |
| Pubmed | GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution. | 1.28e-05 | 2 | 125 | 2 | 26440896 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12742085 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18688271 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22658952 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30049844 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38124277 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19015267 | ||
| Pubmed | Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum. | 1.28e-05 | 2 | 125 | 2 | 19448744 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11950837 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.01e-05 | 91 | 125 | 5 | 28558017 | |
| Pubmed | ARHGAP32 FAT4 PRICKLE1 PHF12 ELP1 SLU7 NBEA SIK3 PI4KB SMARCA2 PREX1 | 2.04e-05 | 638 | 125 | 11 | 31182584 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 2.35e-05 | 94 | 125 | 5 | 23431145 | |
| Pubmed | 2.76e-05 | 162 | 125 | 6 | 25826454 | ||
| Pubmed | Midline radial glia translocation and corpus callosum formation require FGF signaling. | 3.56e-05 | 18 | 125 | 3 | 16715082 | |
| Pubmed | 3.63e-05 | 251 | 125 | 7 | 27507650 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 12906867 | ||
| Pubmed | The discoidin domain receptor DDR2 is a receptor for type X collagen. | 3.84e-05 | 3 | 125 | 2 | 16806867 | |
| Pubmed | The structure of apo human glutamate dehydrogenase details subunit communication and allostery. | 3.84e-05 | 3 | 125 | 2 | 12054821 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 31801062 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 31704028 | ||
| Pubmed | Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway. | 3.84e-05 | 3 | 125 | 2 | 25422375 | |
| Pubmed | The role of tuberous sclerosis complex 1 in regulating innate immunity. | 3.84e-05 | 3 | 125 | 2 | 22412198 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 35396567 | ||
| Pubmed | The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival. | 3.84e-05 | 3 | 125 | 2 | 24445144 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 29784783 | ||
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 3.84e-05 | 3 | 125 | 2 | 29760652 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 29229616 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 30002133 | ||
| Pubmed | Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens. | 3.84e-05 | 3 | 125 | 2 | 30315226 | |
| Pubmed | Isolation of a human brain cDNA for glutamate dehydrogenase. | 3.84e-05 | 3 | 125 | 2 | 3585334 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 36640309 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 37871770 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23560106 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 20670938 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 18242159 | ||
| Pubmed | Identification of disulfide bond formation between MitoNEET and glutamate dehydrogenase 1. | 3.84e-05 | 3 | 125 | 2 | 24295216 | |
| Pubmed | 4.01e-05 | 105 | 125 | 5 | 9628581 | ||
| Pubmed | FGF signaling regulates development by processes beyond canonical pathways. | 4.21e-05 | 19 | 125 | 3 | 33184218 | |
| Pubmed | MPP1 TNIK RPGRIP1L POLR1A TRIO TSC1 ADD1 AFAP1L1 MTR ROBO1 TNS3 | 7.13e-05 | 733 | 125 | 11 | 34672954 | |
| Pubmed | 7.33e-05 | 193 | 125 | 6 | 22589738 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.38e-05 | 281 | 125 | 7 | 28706196 | |
| Pubmed | ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. | 7.65e-05 | 4 | 125 | 2 | 19285943 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 24872547 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 25721396 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 20502675 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 16155788 | ||
| Pubmed | The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. | 7.65e-05 | 4 | 125 | 2 | 23663782 | |
| Pubmed | GLUD1 determines murine muscle stem cell fate by controlling mitochondrial glutamate levels. | 7.65e-05 | 4 | 125 | 2 | 39121856 | |
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 2566156 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 28957665 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 30197236 | ||
| Pubmed | 7.65e-05 | 4 | 125 | 2 | 10480359 | ||
| Pubmed | 8.04e-05 | 63 | 125 | 4 | 11572484 | ||
| Pubmed | PMS1 TNIK DCAF8 ZC3H13 TMEM59 ANKRD26 ELP1 SLU7 SIK3 ADD1 MRPS10 GLUD1 MTR ROBO1 VPS13B PUS7 | 8.87e-05 | 1487 | 125 | 16 | 33957083 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | DDR1 POLR1A TRIO SIK3 ANKRD36C TRRAP LIMK2 PARN ANKRD36 FGFR2 IPMK TNS3 | 1.13e-04 | 910 | 125 | 12 | 36736316 |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 16650578 | ||
| Pubmed | Proximity of the CTLA-1 serine esterase and Tcr alpha loci in mouse and man. | 1.27e-04 | 5 | 125 | 2 | 3182016 | |
| Pubmed | N-terminus of hMLH1 confers interaction of hMutLalpha and hMutLbeta with hMutSalpha. | 1.27e-04 | 5 | 125 | 2 | 12799449 | |
| Pubmed | 1.27e-04 | 5 | 125 | 2 | 16959573 | ||
| Interaction | CDH10 interactions | 6.30e-07 | 12 | 123 | 4 | int:CDH10 | |
| Interaction | ZSCAN18 interactions | 7.84e-06 | 45 | 123 | 5 | int:ZSCAN18 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.94e-07 | 161 | 85 | 8 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD31 CTTNBP2 ANKRD26 ANKRD36C ANKRD18B ANKRD34B ANKRD30A ANKRD36 ANKRD30BL | 2.02e-06 | 242 | 85 | 9 | 403 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.45e-05 | 66 | 85 | 5 | 722 | |
| GeneFamily | Classical BAR domain containing | 6.00e-04 | 8 | 85 | 2 | 1292 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 8.74e-04 | 40 | 85 | 3 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 9.46e-04 | 160 | 85 | 5 | 555 | |
| GeneFamily | WD repeat domain containing | 1.47e-03 | 262 | 85 | 6 | 362 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.65e-03 | 13 | 85 | 2 | 1186 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.54e-03 | 394 | 85 | 7 | 471 | |
| GeneFamily | Cadherin related | 2.84e-03 | 17 | 85 | 2 | 24 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.84e-03 | 17 | 85 | 2 | 1197 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.32e-03 | 163 | 85 | 4 | 590 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL | FAM120B IFI44 OAS3 TSC1 TNFRSF21 TDP2 CEACAM21 TGFBRAP1 SCN1B SIGLEC1 DNASE1L1 TNS3 | 2.61e-06 | 476 | 123 | 12 | M45717 |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_PROJECTION_NEURONS | 6.24e-06 | 147 | 123 | 7 | MM414 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | FAT4 KALRN FAT3 L1CAM NBEA TSC1 CSMD3 NRXN1 ROBO1 SSH2 TMEM151A CSMD1 | 2.04e-05 | 584 | 123 | 12 | M39068 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | SDK2 TRIO PHF12 ZC3H13 ELP1 LAMB3 TNFRSF21 MSH6 PXDN SMARCA2 PARN FGFR2 SSH2 PREX1 VPS13B TNS3 | 2.06e-05 | 1009 | 123 | 16 | M157 |
| Coexpression | HEVNER_CORTEX_ROSTRAL_CORTICAL_PLATE | 4.50e-05 | 42 | 123 | 4 | MM446 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN | 4.56e-05 | 200 | 123 | 7 | M5156 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-12 | 184 | 125 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-12 | 184 | 125 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-12 | 184 | 125 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-08 | 194 | 125 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-08 | 196 | 125 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-07 | 159 | 125 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 174 | 125 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 181 | 125 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 192 | 125 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.25e-06 | 193 | 125 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-06 | 195 | 125 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 196 | 125 | 7 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.43e-06 | 197 | 125 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-06 | 198 | 125 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-06 | 198 | 125 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.58e-06 | 200 | 125 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.54e-06 | 162 | 125 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.78e-06 | 167 | 125 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 9.84e-06 | 174 | 125 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 178 | 125 | 6 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.19e-05 | 180 | 125 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Thalamus-Macroglia|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 181 | 125 | 6 | 4f62b63854a4e9fea6e839f0340e78392c66fb0e | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 1.23e-05 | 181 | 125 | 6 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 183 | 125 | 6 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 183 | 125 | 6 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 189 | 125 | 6 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 1.67e-05 | 191 | 125 | 6 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.72e-05 | 192 | 125 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Control-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 1.72e-05 | 192 | 125 | 6 | 571fd71dad361a8b6c1bf9ad7184a89b3fbec667 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.72e-05 | 192 | 125 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 193 | 125 | 6 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-05 | 193 | 125 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.77e-05 | 193 | 125 | 6 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 195 | 125 | 6 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-05 | 195 | 125 | 6 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-05 | 196 | 125 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 1.93e-05 | 196 | 125 | 6 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-05 | 197 | 125 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.99e-05 | 197 | 125 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-05 | 198 | 125 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | C_01|World / shred on cell type and cluster | 2.04e-05 | 198 | 125 | 6 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-05 | 198 | 125 | 6 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-05 | 198 | 125 | 6 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-05 | 198 | 125 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 199 | 125 | 6 | 043c65bdf54a1bf0e483fea9ffc042ff5b271764 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.10e-05 | 199 | 125 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.10e-05 | 199 | 125 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 199 | 125 | 6 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-05 | 199 | 125 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 199 | 125 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.16e-05 | 200 | 125 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-05 | 200 | 125 | 6 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 200 | 125 | 6 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 124 | 125 | 5 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.72e-05 | 140 | 125 | 5 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 150 | 125 | 5 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 150 | 125 | 5 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 150 | 125 | 5 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.55e-05 | 150 | 125 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.19e-05 | 153 | 125 | 5 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.26e-05 | 79 | 125 | 4 | eddad041c0bc6952d9c68a36bdd78f6d661f0e58 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Igsf8_(Ctps)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.26e-05 | 79 | 125 | 4 | 4c9c3051cb8a9c39c6df20e3fe37242db4b44280 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 154 | 125 | 5 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 154 | 125 | 5 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 157 | 125 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 157 | 125 | 5 | 320d5ac063fd90e26f537475c328b3ae73974bc1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 157 | 125 | 5 | e4b17c267b754c5af95cdf17f629354d1a8a8ad7 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.63e-05 | 159 | 125 | 5 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-04 | 165 | 125 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 165 | 125 | 5 | 7f293f64e7df7710b13016937cdd4f1af326f8c3 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 167 | 125 | 5 | d62d5dec30d006a9cc8f3bc5ccc578e10f105027 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-04 | 168 | 125 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 168 | 125 | 5 | 3d8c431a3c8899383212fe6a7627889c40c5f3ef | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 168 | 125 | 5 | af4c35c0d3f030cef8397c35fa498a71112bb16b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 168 | 125 | 5 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 05b138511039f1255a5f647040b1b9bdf222bd52 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | bf0a97f53d6e3f9ffeaeae0402b010c49a6cccb7 | |
| ToppCell | Club_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 169 | 125 | 5 | 03b303af8a26c6ff196507fe24f5bd3d75d7b1af | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.18e-04 | 170 | 125 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | 5d0d6c1ff610a703ae0b834a12823c5ff9012932 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 171 | 125 | 5 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.32e-04 | 174 | 125 | 5 | fe105550a43b935affc73e32796115d20328a2f8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 174 | 125 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.32e-04 | 174 | 125 | 5 | 9191f6abb37ca65da5105f91e21689d11ec1059b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 175 | 125 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.39e-04 | 176 | 125 | 5 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 177 | 125 | 5 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 177 | 125 | 5 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 177 | 125 | 5 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 179 | 125 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 179 | 125 | 5 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| Drug | 37474A | 5.30e-06 | 7 | 123 | 3 | CID004330138 | |
| Drug | AC1L1B5W | 5.30e-06 | 7 | 123 | 3 | CID000001296 | |
| Drug | N-acetylglutamate | 6.68e-06 | 49 | 123 | 5 | CID000000185 | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; PC3; HT_HG-U133A | 1.29e-05 | 199 | 123 | 8 | 4259_UP | |
| Drug | phenyltriethoxysilane | 2.89e-05 | 2 | 123 | 2 | CID000013075 | |
| Drug | G-3SH | 2.89e-05 | 2 | 123 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 2.89e-05 | 2 | 123 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 2.89e-05 | 2 | 123 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 2.89e-05 | 2 | 123 | 2 | CID000068137 | |
| Drug | x 1 s | 2.89e-05 | 2 | 123 | 2 | CID000409694 | |
| Drug | orthoxine hydrochloride | 2.89e-05 | 2 | 123 | 2 | CID000071471 | |
| Disease | Autistic Disorder | 1.13e-05 | 261 | 119 | 8 | C0004352 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.64e-05 | 152 | 119 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | uric acid measurement | 3.78e-05 | 610 | 119 | 11 | EFO_0004761 | |
| Disease | fascioliasis (biomarker_via_orthology) | 4.83e-05 | 3 | 119 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of endometrium | 4.99e-05 | 18 | 119 | 3 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.99e-05 | 18 | 119 | 3 | C0346191 | |
| Disease | serum gamma-glutamyl transferase measurement | TNIK KALRN NUP210L LMTK2 CSMD3 TENM2 ROBO1 SIGLEC1 TNFAIP2 FGFR2 CSMD1 DNMBP MUC6 | 8.41e-05 | 914 | 119 | 13 | EFO_0004532 |
| Disease | neuroblastoma | 1.10e-04 | 116 | 119 | 5 | EFO_0000621 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 2.39e-04 | 6 | 119 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | response to angiotensin receptor blocker | 2.40e-04 | 30 | 119 | 3 | EFO_0010735 | |
| Disease | obesity (implicated_via_orthology) | 2.44e-04 | 215 | 119 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.65e-04 | 31 | 119 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | cerebrospinal fluid clusterin measurement | 3.81e-04 | 35 | 119 | 3 | EFO_0007657 | |
| Disease | Autism Spectrum Disorders | 3.96e-04 | 85 | 119 | 4 | C1510586 | |
| Disease | calpastatin measurement | 4.44e-04 | 8 | 119 | 2 | EFO_0008065 | |
| Disease | epilepsy (implicated_via_orthology) | 5.32e-04 | 163 | 119 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | cortical thickness | A2M TNIK CTTNBP2 NUP210L FAT3 EML2 TENM2 AFAP1L1 KLHL38 ZBTB34 ROBO1 SSH2 ST18 | 5.65e-04 | 1113 | 119 | 13 | EFO_0004840 |
| Disease | Adenocarcinoma of large intestine | 6.28e-04 | 96 | 119 | 4 | C1319315 | |
| Disease | homocysteine measurement | 8.55e-04 | 46 | 119 | 3 | EFO_0004578 | |
| Disease | osteosarcoma (is_marker_for) | 8.66e-04 | 11 | 119 | 2 | DOID:3347 (is_marker_for) | |
| Disease | Cystic Kidney Diseases | 8.66e-04 | 11 | 119 | 2 | C1691228 | |
| Disease | Schizophrenia | TNIK IL10RA DDR1 ARHGAP32 TRRAP CEACAM21 NRXN1 SMARCA2 MTR FGFR2 CSMD1 | 9.08e-04 | 883 | 119 | 11 | C0036341 |
| Disease | Ciliopathies | 1.04e-03 | 110 | 119 | 4 | C4277690 | |
| Disease | pneumonia, COVID-19 | 1.15e-03 | 113 | 119 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | frontotemporal dementia, age at onset | 1.22e-03 | 13 | 119 | 2 | EFO_0004847, MONDO_0017276 | |
| Disease | Influenza | 1.22e-03 | 52 | 119 | 3 | C0021400 | |
| Disease | Carcinoma, Granular Cell | 1.27e-03 | 116 | 119 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.27e-03 | 116 | 119 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.27e-03 | 116 | 119 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.27e-03 | 116 | 119 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.27e-03 | 116 | 119 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.27e-03 | 116 | 119 | 4 | C0001418 | |
| Disease | trimethylamine-N-oxide measurement | 1.42e-03 | 14 | 119 | 2 | EFO_0010541 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.42e-03 | 14 | 119 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.64e-03 | 15 | 119 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | idiopathic dilated cardiomyopathy | 1.85e-03 | 60 | 119 | 3 | EFO_0009094 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.85e-03 | 60 | 119 | 3 | EFO_0020690 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 1.87e-03 | 16 | 119 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | Dyskeratosis Congenita | 1.87e-03 | 16 | 119 | 2 | C0265965 | |
| Disease | Multiple congenital anomalies | 2.11e-03 | 17 | 119 | 2 | C0000772 | |
| Disease | banks of the superior temporal sulcus volume measurement | 2.11e-03 | 17 | 119 | 2 | EFO_0010286 | |
| Disease | Ulcerative Colitis | 2.13e-03 | 63 | 119 | 3 | C0009324 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.13e-03 | 566 | 119 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | susceptibility to hepatitis B infection measurement | 2.23e-03 | 64 | 119 | 3 | EFO_0008405 | |
| Disease | Intellectual Disability | 2.29e-03 | 447 | 119 | 7 | C3714756 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 2.64e-03 | 19 | 119 | 2 | EFO_0002609, GO_0031427 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 2.64e-03 | 19 | 119 | 2 | OBA_2045199 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | superior temporal gyrus volume measurement | 2.64e-03 | 19 | 119 | 2 | EFO_0010331 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.65e-03 | 68 | 119 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.76e-03 | 69 | 119 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.88e-03 | 70 | 119 | 3 | EFO_0008082 | |
| Disease | Endometrial Carcinoma | 3.11e-03 | 72 | 119 | 3 | C0476089 | |
| Disease | lung cancer | 3.22e-03 | 21 | 119 | 2 | MONDO_0008903 | |
| Disease | pentachlorophenol measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.24e-03 | 73 | 119 | 3 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 3.37e-03 | 74 | 119 | 3 | EFO_0007886 | |
| Disease | behavioural disinhibition measurement | 3.50e-03 | 75 | 119 | 3 | EFO_0006946 | |
| Disease | triacylglycerol 54:6 measurement | 3.53e-03 | 22 | 119 | 2 | EFO_0010424 | |
| Disease | portal hypertension (biomarker_via_orthology) | 3.53e-03 | 22 | 119 | 2 | DOID:10762 (biomarker_via_orthology) | |
| Disease | glaucoma | 3.56e-03 | 154 | 119 | 4 | MONDO_0005041 | |
| Disease | Disproportionate short stature | 3.77e-03 | 77 | 119 | 3 | C0878659 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.86e-03 | 23 | 119 | 2 | C1335177 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 3.86e-03 | 23 | 119 | 2 | DOID:0050156 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EISFYNATDGSHIYT | 471 | O00478 | |
| SYDFLHIYEGEDSNS | 1501 | Q96PZ7 | |
| DYSSAFNITSNGHEV | 2531 | Q7Z407 | |
| AHSSRQAYGASLYEQ | 441 | Q2NKJ3 | |
| VGSVTYQEEAARHTY | 381 | A1IGU5 | |
| DLHFQNVTLEDTGYY | 106 | Q3KPI0 | |
| EAVYLNDSTYDGHTV | 206 | Q08345 | |
| DNADLYYSITGTNNH | 1346 | Q6V0I7 | |
| TALHYAVYNEGTSLA | 136 | A2A2Z9 | |
| YTSNDSYIVHSGDLR | 26 | Q9BXX3 | |
| LGHLTSEYDTDRNSY | 361 | Q6XZF7 | |
| GRTALHYAVYNEDTS | 131 | A6QL64 | |
| GNTALHYAVYNEDIS | 146 | Q9UPS8 | |
| ANYYSNATTDEHGLV | 391 | P01023 | |
| YQYATEDGLIHTNDQ | 656 | Q6NXG1 | |
| TASEQLHEAGYDAYI | 371 | O95453 | |
| HSSYSALVYAINSED | 116 | A5PLL1 | |
| GRTALHYAVYNEDTS | 131 | Q5JPF3 | |
| YSDNAVISEHVANYE | 976 | Q8N7Z5 | |
| ESHDYYSLGDIVANG | 146 | Q8N635 | |
| LQHGNYLVTETYSAS | 926 | P32926 | |
| EYGSINHTYHLDVVE | 236 | P21802 | |
| THTQDGHGEYQYTQE | 1136 | Q6W4X9 | |
| GSYHVDESRNYISNS | 426 | P58400 | |
| FNTASLVYHEEGYLN | 286 | P18428 | |
| LVYHEEGYLNFSITD | 291 | P18428 | |
| NTITLEVHQAYSTEY | 676 | Q68CZ1 | |
| DTTGYAYLNHEVSRV | 221 | Q9UBC5 | |
| EDGDAYALVQHATLY | 106 | P53671 | |
| SLEAEDAATYYCHQS | 96 | A0A0C4DH24 | |
| DLYSVSDVQYNSHGA | 1001 | O43451 | |
| NDLYSVSDVQYNSHG | 1896 | O43451 | |
| IYLFNSSHSDGAQYV | 411 | Q5TAQ9 | |
| SHTEIGVSYQYALDL | 336 | O60229 | |
| EAELAQYYSHFTALG | 11 | Q5T7B8 | |
| NSLGSARHAYYVTVE | 316 | P32004 | |
| LVIHSLDYSDQGNYS | 576 | P32004 | |
| DAHNLSVGSDYYIQL | 541 | Q8IWU2 | |
| SSQQYQDISIAYGEH | 981 | O95163 | |
| YDLTAVTLDLYHSNG | 81 | Q13651 | |
| GSYHVDESRNYISNS | 1431 | Q9ULB1 | |
| QSEEGLGSDDHQYIY | 71 | Q13316 | |
| STHYHSLVEDYSQNV | 1246 | P52701 | |
| SVTVVSQYDNLEDYH | 2016 | A7KAX9 | |
| HYHTTNDLVQEYDST | 516 | O95800 | |
| VHSDSYETENQHYGR | 186 | Q8NFU5 | |
| VSTADNIYVNHSFEG | 1326 | Q9UHC9 | |
| QNADLYGQYAHATSD | 726 | Q96MT3 | |
| CSHDYLAIYDGANTS | 3091 | O60494 | |
| SEDHIIGAYAEESYQ | 56 | Q8TCB0 | |
| HKTQVLSSYVYNDED | 106 | P49184 | |
| NYDYASNSVVLHLDS | 241 | Q7Z5L3 | |
| DSLATYAYEGNDSIA | 731 | Q9Y6N8 | |
| YAYEGNDSIAESLSS | 736 | Q9Y6N8 | |
| DINYSCEDGHSALYS | 736 | Q8WZ74 | |
| IADTYASTIGHYDIN | 236 | P00367 | |
| HAAGFAYTYQNETRS | 556 | Q96PZ2 | |
| SAHQGSTRELESDYY | 4381 | Q8TDW7 | |
| NVAIAVTYNHDGSYS | 561 | Q96RQ3 | |
| AHANEQAEYEFISSG | 626 | Q9H992 | |
| NYYSHRVENVASSSG | 76 | Q13751 | |
| VVYSHDGTELLASYN | 396 | A6NGE4 | |
| YAHYFDLSLVNNGVD | 426 | Q00013 | |
| AVGSHDNLVYVYTVD | 476 | O95834 | |
| LYQFYHEDVTLGNSS | 331 | Q96LA5 | |
| TNYEIEVAAYNSAGL | 761 | Q58EX2 | |
| ATYAYEGNDSIADSL | 736 | Q9ULB4 | |
| AASYHLARQYESQEE | 1011 | Q96RY7 | |
| QYHSEESQIYLSGFL | 226 | P54277 | |
| IADTYASTIGHYDIN | 236 | P49448 | |
| LQEADYEVASYGLQH | 156 | Q96EK7 | |
| EYFEEQLTTVNGSYH | 406 | Q5VU65 | |
| VDLIHSYSNAGEYST | 911 | Q9Y6K5 | |
| SCYALTYNTHIDEDN | 91 | O75818 | |
| GRVVYQHDGSNTYSD | 501 | P0C091 | |
| TDHYFYVTIGNLDSV | 1411 | P0C091 | |
| IHTGSVNTYSYTDVN | 3451 | O75445 | |
| EHLTGSTADVYLEYI | 146 | P82664 | |
| HVVIYDASDQGLYSA | 96 | P25325 | |
| YSNDIHAIANTYGIE | 1601 | O95602 | |
| RGSQSYYTVAHAISE | 696 | P51531 | |
| AAFSNGYTADHERAY | 446 | O75509 | |
| DAYTTTQVYHERVNT | 186 | Q8IW70 | |
| IYYSHENLIEDFNSG | 171 | P12259 | |
| HGLEDSNISYGSYEE | 1791 | P21675 | |
| NLTAYQHGSDVYFTT | 496 | P57071 | |
| NVFHYLTYEGSVNLD | 2516 | Q8NFP9 | |
| GYQHNFDTYDDSLIT | 186 | Q16819 | |
| TSIAQADYGLEHLAY | 101 | Q99707 | |
| HYELLNYSEHGTTVD | 851 | Q96QT6 | |
| NYSEHGTTVDNVLYS | 856 | Q96QT6 | |
| GSFSIQYTYHVDAND | 61 | P04279 | |
| VEDGTADYHSNGYTV | 341 | Q8TCU6 | |
| ATYIEEDDVNNYSIH | 511 | Q96PZ0 | |
| EQTLQSLRSDAYDHY | 361 | Q9Y2K2 | |
| SYTIDSNQEFLAHGA | 306 | Q8NG04 | |
| YSGDDAYATDAILNS | 1531 | Q9NT68 | |
| GSQEHRDSYAYLNAS | 366 | O75626 | |
| GDAYTTTQVYHERAD | 171 | Q8N4L1 | |
| LYNDHGVIVDYNTTD | 311 | Q68CZ2 | |
| LDYFLQEHGSYTTEA | 631 | Q9UBF8 | |
| QEHGSYTTEAFLSAQ | 636 | Q9UBF8 | |
| YSYGQCSEDTHIAAA | 561 | O60284 | |
| VYGNTAVHYAVNSEN | 136 | A7E2S9 | |
| EVSYLYVNTADLHSG | 51 | Q8TED9 | |
| SVGESVEEAFYYIHN | 306 | P35611 | |
| NAESNGLYSSEYVHS | 656 | Q03692 | |
| TQYIIHNYSTGVSQD | 186 | Q8WUH2 | |
| TEAYSQSDEQYACHL | 101 | Q9BXS4 | |
| HVIDVDSGNSYDIYI | 1216 | Q9UKE5 | |
| AEFGVVAAYAESYHQ | 241 | Q03169 | |
| YEDGYSVSHQISARF | 271 | Q92574 | |
| NETHATYSNTLYLAD | 396 | P07911 | |
| VSYYESHINSDQSSV | 206 | Q76I76 | |
| QTLYETLASYTHNIE | 551 | Q9UBZ9 | |
| IFITNVTYNHSGDYE | 106 | Q07699 | |
| QHAYSENADFSGLTE | 326 | P05543 | |
| VDLNGTSYHYNDLVS | 696 | Q92626 | |
| SNYEIITGHEEGYFT | 166 | O95551 | |
| LAQTEDYVEYSRHGT | 391 | O95391 | |
| YEGAAAATDIVDSQY | 401 | O15178 | |
| HSNSEEYNISVDESY | 1196 | Q9Y6N7 | |
| YDYSGQRQVVSHSAD | 61 | Q9BZZ2 | |
| ESATEASYNVSYHIA | 191 | Q49AG3 | |
| ASYNVSYHIALSGEA | 196 | Q49AG3 | |
| YSHETASTDDAGIQY | 591 | Q6P2C0 | |
| YQEHLGVTYLTLSED | 3236 | Q7Z7G8 | |
| QHSEYEYGNDLSLST | 351 | Q9UL58 | |
| LAASLNHYAGYEQVT | 116 | Q9NYA1 | |
| AHNVDRNLTIDTYYD | 306 | Q96PF1 | |
| YSETATAIAYEQHGF | 2771 | Q9Y4A5 | |
| SDNGDINYDYVHELS | 151 | Q5T200 | |
| YEHITLAYSEVSQDG | 491 | O75962 | |
| DFGDAVQLNTTYYIH | 2936 | O75962 | |
| GSVLQHAYSYSQAAS | 276 | Q8NCN2 | |
| DQIVSYVYTGEAHIA | 86 | Q2WGJ6 | |
| YVYTGEAHIATDNVL | 91 | Q2WGJ6 |